Physician profile
Patrick M Mcmahon
NPI 1114996709
$1,356.63
in general payments reported to CMS, 2019-2025
9 companies · $215 in 2025
The $215 reported for 2025 was more than what 90% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.82 · 2022: $547 · 2023: $268 · 2024: $250 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $733.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $588.13 | 2022-2025 | Entyvio, Eohilia |
| Abbvie INC. | $164.90 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $157.49 | 2021-2025 | Xifaxan |
| Intercept Pharmaceuticals, INC. | $147.18 | 2021-2025 | Ocaliva |
| Qol Medical, LLC | $137.42 | 2022-2023 | Sucraid |
| Nestle Healthcare Nutrition INC. | $70.22 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $42.75 | 2024-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $27.11 | 2023-2024 | Dificid, Zerbaxa, Zinplava |
| Genzyme Corporation | $21.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mcmahon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.